269 related articles for article (PubMed ID: 26209312)
1. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
Andria N; Henig O; Kotler O; Domchenko A; Oren I; Zuckerman T; Ofran Y; Fraser D; Paul M
J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
Crusio R; Rao S; Changawala N; Paul V; Tiu C; van Ginkel J; Chapnick E; Kupfer Y
Scand J Infect Dis; 2014 Jan; 46(1):1-8. PubMed ID: 24206450
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea.
Kim T; Chong YP; Park SY; Jeon MH; Choo EJ; Chung JW; Lee HK; Moon C; Kim DM; Peck KR; Kim YS
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):457-61. PubMed ID: 24462178
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for carbapenem resistant bacteraemia and mortality due to gram negative bacteraemia in a developing country.
Kalam K; Qamar F; Kumar S; Ali S; Baqi S
J Pak Med Assoc; 2014 May; 64(5):530-6. PubMed ID: 25272538
[TBL] [Abstract][Full Text] [Related]
5. The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.
Zak-Doron Y; Dishon Benattar Y; Pfeffer I; Daikos GL; Skiada A; Antoniadou A; Durante-Mangoni E; Andini R; Cavezza G; Leibovici L; Yahav D; Eliakim-Raz N; Carmeli Y; Nutman A; Paul M;
Clin Infect Dis; 2018 Nov; 67(12):1815-1823. PubMed ID: 29718143
[TBL] [Abstract][Full Text] [Related]
6. Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study.
Lanini S; Costa AN; Puro V; Procaccio F; Grossi PA; Vespasiano F; Ricci A; Vesconi S; Ison MG; Carmeli Y; Ippolito G;
PLoS One; 2015; 10(4):e0123706. PubMed ID: 25835018
[TBL] [Abstract][Full Text] [Related]
7. Effect on 30-day mortality and duration of hospitalization of empirical antibiotic therapy in CRGNB-infected pneumonia.
Li R; Tang H; Xu H; Cui K; Li S; Shen J
Ann Clin Microbiol Antimicrob; 2021 Mar; 20(1):15. PubMed ID: 33678191
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
9. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.
Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Karapanagiotou A; Karyoti A; Gritsi-Gerogianni N; Tsakris A; Roilides E
J Hosp Infect; 2018 Aug; 99(4):396-404. PubMed ID: 29792971
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients.
Jia Y; Li Y; Liu Y; Yang Z; Chen X; Liu Y
Front Cell Infect Microbiol; 2022; 12():1098856. PubMed ID: 36710978
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection.
Qu J; Feng C; Li H; Lv X
Int J Antimicrob Agents; 2021 Mar; 57(3):106284. PubMed ID: 33484833
[TBL] [Abstract][Full Text] [Related]
12. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
Cherif H; Kronvall G; Björkholm M; Kalin M
Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Scand J Infect Dis; 2011 Mar; 43(3):202-8. PubMed ID: 21142623
[TBL] [Abstract][Full Text] [Related]
14. Is surveillance for colonization of carbapenem-resistant gram-negative bacteria important in adult bone marrow transplantation units?
Demiraslan H; Cevahir F; Berk E; Metan G; Cetin M; Alp E
Am J Infect Control; 2017 Jul; 45(7):735-739. PubMed ID: 28214159
[TBL] [Abstract][Full Text] [Related]
15. Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study.
Liang Q; Chen J; Xu Y; Chen Y; Huang M
Antimicrob Resist Infect Control; 2022 Jun; 11(1):89. PubMed ID: 35733230
[TBL] [Abstract][Full Text] [Related]
16. Impact of Preemptive Granulocyte Infusions During Febrile Neutropenia in Patients Colonized with Carbapenem-Resistant Gram-Negative Bacteria Undergoing Haploidentical Transplantation.
Jaiswal SR; Bhakuni P; Bhagwati G; Joy A; Chakrabarti A; Chakrabarti S
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1621-1628. PubMed ID: 31048086
[TBL] [Abstract][Full Text] [Related]
17. Prediction of carbapenem-resistant gram-negative bacterial bloodstream infection in intensive care unit based on machine learning.
Liang Q; Ding S; Chen J; Chen X; Xu Y; Xu Z; Huang M
BMC Med Inform Decis Mak; 2024 May; 24(1):123. PubMed ID: 38745177
[TBL] [Abstract][Full Text] [Related]
18. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
Righi E; Peri AM; Harris PN; Wailan AM; Liborio M; Lane SW; Paterson DL
J Antimicrob Chemother; 2017 Mar; 72(3):668-677. PubMed ID: 27999023
[TBL] [Abstract][Full Text] [Related]
19. Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
Alves MD; Ribeiro VB; Tessari JP; Mattiello F; De Bacco G; Luz DI; Vieira FJ; Behle TF; Pasqualotto AC; Zavascki AP
J Antimicrob Chemother; 2014 Jun; 69(6):1681-7. PubMed ID: 24474430
[TBL] [Abstract][Full Text] [Related]
20. Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections.
Tabak YP; Sung AH; Ye G; Vankeepuram L; Gupta V; McCann E
J Hosp Infect; 2019 May; 102(1):37-44. PubMed ID: 30503367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]